Fluidic Sciences Acquires Business and Assets of Sphere Bio to Accelerate Single-Cell and Protein Interaction Discovery News Fluidic Sciences Acquires Business and Assets of Sphere Bio to Accelerate Single-Cell and Protein Interaction Discovery
Sphere Bio awarded Best Droplet Microfluidic Technology Company 2025 News Sphere Bio awarded Best Droplet Microfluidic Technology Company 2025
APAC distribution network expanded to strengthen presence in region News APAC distribution network expanded to strengthen presence in region
Cyto-Cellect® Human IgG Kappa and Viability Assay Kit launched for efficient single-cell selection News Cyto-Cellect® Human IgG Kappa and Viability Assay Kit launched for efficient single-cell selection
Sphere Bio joins MabDesign to strengthen connections in European biotherapeutics News Sphere Bio joins MabDesign to strengthen connections in European biotherapeutics
Sphere Bio launches Cyto-Mine® Chroma and announces Early Access Program News Sphere Bio launches Cyto-Mine® Chroma and announces Early Access Program
Cyto-Cellect® Fc Fusion Assay Kit launched to expedite cell line development for fusion proteins News Cyto-Cellect® Fc Fusion Assay Kit launched to expedite cell line development for fusion proteins
Sphere Bio strengthens global commercial teams and establishes direct sales and support channel in North America News Sphere Bio strengthens global commercial teams and establishes direct sales and support channel in North America
Cyto-Mine® Chroma announced to accelerate and streamline workflows News Cyto-Mine® Chroma announced to accelerate and streamline workflows
